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cartilage by fluorescence lifetime imaging
Xiangnan Zhou,a Anne K. Haudenschild,a Benjamin E. Sherlock,a Jerry C. Hu,b J. Kent Leach,a,c
Kyriacos A. Athanasiou,b and Laura Marcua,*
aUniversity of California, Department of Biomedical Engineering, Davis, California, United States
bUniversity of California, Department of Biomedical Engineering, Irvine, California, United States
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Abstract. Glycosaminoglycan (GAG) loss is an early marker of osteoarthritis, which is a clinical late stage dis-
ease that affects millions of people worldwide. The goal of our study was to evaluate the ability of a fiber-based
fluorescence lifetime imaging (FLIm) technique to detect GAG loss in articular cartilage. Native bovine cartilage
explants (n ¼ 20) were exposed to 0 (control), 0.5 (low), or 1 U∕mL (high) concentrations of chondroitinase ABC
(cABC) to create samples with different levels of GAG loss. FLIm assessment (excitation: 355 nm; detection:
channel 1: 375 to 410 nm, channel 2: 450 to 485 nm, channel 3: 530 to 565 nm) was conducted on depth-
resolved cross-sections of the cartilage sample. FLIm images, validated with histology, revealed that loss of
GAG resulted in a decrease of fluorescence lifetime values in channel 2 (Δ ¼ 0.44 ns, p < 0.05) and channel
3 (Δ ¼ 0.75 ns, p < 0.01) compared to control samples (channel 2: 6.34 ns; channel 3: 5.22 ns). Fluorescence
intensity ratio values were lower in channel 1 (37%, p < 0.0001) and channel 2 (31% decrease, p < 0.0001)
and higher in channel 3 (23%, p < 0.0001) relative to control samples. These results show that FLIm can
detect the loss of GAG in articular cartilage and support further investigation into the feasibility of in vivo FLIm
arthroscopy. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this
work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.23.12.126002]
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Paper 180522RR received Aug. 30, 2018; accepted for publication Nov. 27, 2018; published online Dec. 21, 2018.
1 Introduction
Articular cartilage is the near frictionless tissue at the end of
long bones that allows smooth movement of joints and absorbs
shock. Cartilage degenerative diseases such as osteoarthritis
(OA) are major causes of disability worldwide1 and have a
substantial contribution to healthcare cost.2 This large economic
burden will continue to increase as the population ages. Clinical
OA is a late-stage condition for which disease-modifying
opportunities are limited. However, OA typically develops over
decades, offering a long window of time to potentially alter its
course. As such, characterization of pre- or early-OA disease
states will be critical to support a paradigm shift from palliation
of late disease toward prevention.3 Unfortunately, early diagno-
sis of OA is still a challenging, unmet clinical need that must be
addressed.
Cartilage extracellular matrix (ECM) is composed primarily
of 15% to 30% glycosaminoglycan (GAG) (per dry weight),
50% to 75% collagen (per dry weight), and 70% to 80%
water (per wet weight). The remaining balance of dry weight
includes minor protein molecules and chondrocytes.4,5 The
mechanical properties of articular cartilage are determined by
the biochemical composition of the main tissue constituents,
GAG and collagen, creating a structure–function relationship
in which GAG resists compressive loading and collagen resists
tensile loading within the tissue.6 During the early stages of
OA, the changes in cartilage are clinically silent. No visual,
functional, or mechanical alterations of articular cartilage appear
detectable. Gradual GAG loss is the first observable indication
of OA. Left untreated, it will lead to a “death spiral” of increas-
ing matrix degradation and reduced biomechanical properties.7
As a result, normal loading increases matrix damage, leading to
a positive feedback loop of cartilage damage, pain, and destruc-
tion. This deterioration continues until the cartilage completely
loses its ability to withstand load and is worn away to expose
subchondral bone.8 Therefore, the detection of GAG loss is criti-
cal for the early diagnosis of OA.
Imaging modalities are an integral part of the diagnosis
of OA. Conventional imaging modalities like arthroscopic
imaging, standard radiography, ultrasonography, and magnetic
resonance imaging (MRI) are widely used in daily clinical
diagnosis.9–11 Despite that, arthroscopy is primarily a qualitative
assessment technique that falls short of the laboratory assess-
ment standards of histopathology, biochemical analysis, and
biomechanical testing. Both radiography and ultrasound fail
to provide critical information regarding the biochemical com-
position of the cartilage ECM. Conventional MRI allows accu-
rate assessment of both cartilage morphology and biochemical
composition (collagen ultrastructure and GAG concentration)
but still suffers from low clinical image resolution.12
Over the past decade, optical imaging modalities have been
studied to evaluate the biochemical makeup and structural
organization of cartilage and are being actively explored for
utility in cartilage research and OA diagnosis. This includes
laser scanning confocal microscopy,13 second harmonic gener-
ation microscopy, multiphoton microscopy,14 Fourier transform
infrared imaging and spectroscopy,15 and Raman spectroscopy.16
Unfortunately, challenges, including the complexity and high cost
of instrumentation and low data acquisition speed, hamper their
clinical translation. Moreover, optical coherence tomography*Address all correspondence to Laura Marcu, E-mail: lmarcu@ucdavis.edu
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(OCT) allowing evaluation of cartilage microstructure associ-
ated with cartilage health has been used arthroscopically as
a translational research tool for early diagnosis of OA.17,18
Still, OCT lacks the ability to provide biochemical information.
Therefore, there is a need for clinical compatible imaging
modalities for in vivo assessment of biochemical composition
related to cartilage health. Fiber-based time-resolved fluores-
cence lifetime imaging (FLIm) has the potential to address
this need. FLIm with a lower-case m was used as abbreviation
to distinguish our fiber-based technology from fluorescence life-
time microscopy (FLIM). Over the past decade, several groups
have reported that FLIm may be used for disease diagnosis and
tissue characterization with applications in numerous clinical
areas, including oncology, cardiology, and ophthalmology.19
Multimodal instrumentation combining FLIm and ultrasound
has also been used to monitor matrix composition and
mechanical properties of engineered cartilage tissue during
maturation.20,21 Recent advantages in FLIm devices using
miniature fiber optics probes, along with fast electronics
enabling fast data acquisition speed, analysis, and real-time
display22 make this technique highly compatible with modern
clinical arthroscopes. Hence, the goal of the present study
was to investigate the feasibility of using FLIm for early detec-
tion of cartilage disease. Specifically, this study focused on
(1) evaluation of fluorescence properties of native articular car-
tilage and their variation across different depth-resolved zones,
(2) investigation of whether FLIm can detect the depletion of
major cartilage biochemical constituents involved in develop-
ment of OA, namely GAG, and (3) determining whether
FLIm parameters can be used to infer the level of GAG loss
in cartilage.
2 Materials and Methods
2.1 Cartilage Harvest
Articular cartilage was excised as full thickness cylindrical
osteochondral plugs (n ¼ 25) from a juvenile (2-week-old)
bovine femoral head obtained from an abattoir (Research 87,
Boylston, MA) within 48 h of death. Cartilage explants were
wrapped in gauze and soaked in phosphate-buffered saline
(PBS) with protease inhibitors (2-nM phenylmethylsulfonyl
fluoride, 10-mM N-ethyl malemide, 2-mM ethylene diamine
tetraacetatic acid, and 5-mM benzamidine-HCl) as previously
described,23 underwent three freeze thaw cycles to lyse cells,
and stored at −20°C in protease inhibitor until imaging
[Fig. 1(a)].
2.2 Proteolytic Enzyme Treatments
Cartilage explants were placed one sample per well in six
well plates (Costar, Corning, New York) in 6 mL of PBS
Fig. 1 (a) Schematic diagram of the study protocol. Harvest and treatment of bovine articular cartilage
samples in untreated (control) and cABC groups. Zonal en-face imaging was conducted on samples from
different depths of cartilage from control group. Cross-sectional imaging was conducted on both control
and cABC treatment groups. (b) Schematic diagram of the FLIm system. FLIm images were acquired by
raster scanning of the optical fiber. (c) Spectral channels of the FLIm instrument: channel 1 = 375 to
410 nm, channel 2 = 450 to 485 nm, and channel 3 = 530 to 565 nm. The reference emission spectrum
of collagen (red) and GAG (blue)24 was also overlaid.
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(Sigma-Aldrich, St. Louis, Missouri). To remove proteoglycans,
chondroitinase ABC (cABC) (Sigma-Aldrich) was added to
a final concentration of 0 U∕mL (control), 0.5 U∕mL (low
cABC), or 1 U∕mL (high cABC) of cABC per well. All treat-
ments included 50 U∕mL salt activated nuclease (ArcticZymes,
Tromsø, Norway), 0.02% ethylenediaminetetraacetic acid (Life
Technologies, Grand Island, New York), and 1% penicillin/
streptomycin/fungizone (Lonza, Basel, Switzerland). Treatment
occurred for 10 h at 37°C on a rotatory plate at 35 revolutions/
min. After treatment, explants were washed in fresh PBS for
12 h to remove residual enzymes.
2.3 FLIm Assessment of Articular Cartilage
After enzymatic treatment, full thickness cartilage samples were
cut perpendicular to the surface into two half-cylinders. Samples
were placed on a custom, glass sample holder for cross-sectional
FLIm assessment. To study the depth-dependent fluorescence
lifetime (LT) of cartilage, the other half of the cylinder was
sectioned using a custom cutting jig into approximately the
superficial, middle, and deep zones of the cartilage and imaged
en-face [schematic is shown in Fig. 1(a)]. During FLIm
acquisition, samples were immersed in PBS to maintain
hydration. The fluorescence LT images were reconstructed
from FLIm measurements and coregistered with histology
images using the shape of the tissue sections. Regions of
interest (ROIs) were selected in FLIm images following co-
registration based on histology features for further analysis.
Following imaging, cartilage samples were placed in formalin
and processed routinely for histologic analysis. MATLAB
(Mathworks, Inc.) software was used for image co-registration
and ROIs selection.
2.4 FLIm Instrumentation
FLIm images were acquired using a prototype fiber-based point
scanning principle and system, which had been previously
reported.25,26 A schematic of the system is shown in Fig. 1(b).
A frequency tripled Nd:YAG microchip laser (STV-02E-1x0,
TEEM photonics) with repetition rate of 4K and pulse
width of 600 ps was used as fluorescence excitation light
source. Fluorescence excitation and emission were guided to
and from the target by a single 400-μm core diameter all silica
multimode fiber (FVP400440480, Polymicro). A wavelength
selection module was used to separate fluorescence emission
into three nonoverlapping spectral bands (channel 1 = 375
to 410 nm, channel 2 = 450 to 485 nm, channel 3 = 530 to
565 nm) [Fig. 1(c)]. The spectral channels were temporally
separated by passing the emission pulse through three
delay fibers (FVP400440480, Polymicro) of different lengths.
A single microchannel plate photomultiplier tube (R3809U-
50, Hamamatsu) detector was used to detect the temporally
multiplexed signal. Neutral density (ND) filter with ND ¼ 1.3
was used to attenuated signals in detection channels 1 and 2
so all spectral channels had similar signal intensity. Raster
scanning was achieved using a motorized three axis translation
stage (MX80L, Parker) with scanning speed up to 500 mm∕s.
FLIm images were acquired with 200 or 400 μm square pixel
size over a 10 mm × 10 mm scanning area. The data acquisition
time for each pixel was 8 ms, and the scanning speed was
determined based on desired pixel size.
2.5 FLIm Parameters
Following the acquisition of the fluorescence decay signal, non-
negative constrained least-square deconvolution based on the
Laguerre expansion method was performed to determine the
fluorescence response of cartilage samples.27 The average LT
and intensity ratios were derived from the deconvolved fluores-
cence decay. The average LTwas defined as the average amount
of time a fluorophore stays in the excited state. Mathematically,
it is the expected value of the probability distribution of detected
photons, which was obtained by normalizing the deconvolved
decay by the total area under the curve. Intensity ratios were
defined as the ratio of fluorescence intensity at each channel
to the sum of all three intensity channels. The standard deviation
of the recovered LT was <0.1 ns.
2.6 Histology
After FLIm assessment, samples were fixed in 10% neutral buf-
fered formalin, paraffin embedded, and then sectioned parallel
to the imaging plane at 10 μm. The sections were stained with
hematoxylin and eosin (H&E) for general morphology, safranin
O for GAG, and picrosirius red (PSR) for total collagen follow-
ing routine procedures. The sections were imaged using an
inverted microscope (BZ-X700, Keyence).
2.7 Fluorescence Lifetime vs. Distance from
Cartilage Surface
To study the variability of fluorescence LT inside the cartilage
tissue, we studied the change of fluorescence LT as a function of
distance from the cartilage surface. To determine the distance
from the cartilage surface of each pixel, the location of cartilage
surface in cross-sectional images was first determined by find-
ing the pixels with maximum fluorescence emission intensity
gradient. Those pixels were used as a reference point for dis-
tance calculation. After that, the distance to cartilage surface
of every pixel inside cross-sectional LT images was calculated.
A distribution of fluorescence LT at a given distance can be
generated by combining data from all cross-sectional images
(n ¼ 3).
2.8 Region of Interest Selection
ROIs were drawn manually based on the amount of safranin O
staining in histology images. The GAG depleted region that had
no or minimal safranin O staining was segmented manually as
ROIs for data analysis. The thickness of each ROI, average value
of fluorescence LT, and intensity ratio within each ROI were
calculated and used for statistical analysis.
2.9 FLIm Image Segmentation
A simple threshold-based segmentation algorithm was devel-
oped and tested for its ability to detect GAG depletion in
cross-sectional FLIm images. Channel 1 intensity ratio was
used as the parameter for the segmentation algorithm and 0.25
was set as the threshold based on receiver operating character-
istic analysis. The average depletion thickness was calculated
and used for statistical analysis.
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2.10 Statistics
In this study, n ¼ 25 biopsy samples were harvested from
the same joint. We used n ¼ 3 to study the depth-dependent
LT of native cartilage. We used the remaining n ¼ 22 (control
= 7, low cABC ¼ 8, high cABC ¼ 7) to study the effect of
GAG loss on cartilage fluorescence properties. Two samples
were excluded from data analysis due to improper histology
sectioning, resulted in the final total sample number of
n ¼ 20 (control: n ¼ 6, low cABC: n ¼ 8, high cABC: n ¼ 6).
Statistical analysis was performed using Student’s t-tests and
one-way ANOVA with Tukey’s posthoc analysis, where appli-
cable. All of the statistical analysis was performed with R
Statistical Software (Foundation for Statistical Computing,
Vienna), and p < 0.05 were considered statistically significant.
3 Results
3.1 Depth-Dependent Lifetime of Native Articular
Cartilage
Cross-sectional FLIm images [Fig. 2(a)] showed that fluores-
cence LT in channel 1 varied with cartilage depth. The region
closest to the cartilage surface had a LT of 5.7 0.12 ns while
the middle and deep part of cartilage had a longer LT of
6.1 0.08 ns (p < 0.0001). The same trend was also presented
in the zonal FLIm images [Fig. 2(a)]. This was further confirmed
by the violin plot as the distributions of LT from both cross-
sectional and zonal imaging shifted to higher LT values in
middle and deep zone [Fig. 2(b)]. This trend was observed
for all samples as depicted by the box-plot of LT distribution
from all samples (n ¼ 3), which demonstrated that the LT
increases with distance from cartilage surface. This increase was
most noticeable within 500 μm from the surface [Fig. 2(c)].
In addition, changes of fluorescence LT were also associated
with morphological heterogeneities. Macrostructures with shorter
LT were also presented in both cross-section and en-face FLIm
LT images [Fig. 2(a)]. No significant depth-dependent LT
changes were observed in other spectral channels.
3.2 Detection of GAG-Depletion using FLIm
Safranin-O stained histology images showed that compared
to untreated (control) cartilage, enzymatic treatment of cABC
almost completely depleted GAG content within 1 mm distance
from cartilage surface [Fig. 3(a)]. The depletion of GAG
resulted in significant decreases in fluorescence LT in both
detection channel 2 (p < 0.05) and channel 3 (p < 0.01) and sig-
nificant changes in the intensity ratios in all collection channels
(p < 0.0001) [Fig. 3(b)].
A segmentation algorithm based on channel 1 intensity
ratio was able to identify regions of GAG depletion in both
low and high cABC treated FLIm images [Fig. 4(a)].
The untreated control group had an average depleted layer
thickness of ∼0.1 mm, whereas low (1 U∕mL) and high
(2 U∕mL) C-ABC concentration treatment resulted in an
average depletion layer thickness of 0.3 mm and 0.7 mm,
respectively. Average depletion thickness from high cABC
treatment group was significantly higher than that of control
(untreated) (p < 0.01) and low cABC (p < 0.01) treatment
group. However, no significant difference was observed in
average depletion region thickness between control and low
cABC treatment group [Fig. 4(b)].
Fig. 2 Channel 1 (375 to 410 nm) fluorescence LT increases with distance from articular cartilage
surface (n ¼ 3). (a) Representative cross-section and zonal FLIm image of native bovine articular
cartilage. Scalebar ¼ 1 mm. Dashed line represents estimated location of cut of superficial, middle
and deep zone. (b) Violin plot of LT distribution of different zones of articular cartilage acquired through
zonal and x -section imaging. The LT of superficial zone is significantly lower than that of middle and deep
zones (***p < 0.001). (c) A box plot of average LT versus distance from cartilage surface for all samples
(n ¼ 3). Each box represents all data points from all samples at the corresponding distance from cartilage
surface. Five values are highlighted: the extremes, the upper and lower quantiles, and the median.
A clear increase of LT with distance from cartilage surface is observed. The increase is most prominent
within the first 0.5 mm of cartilage surface.
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Fig. 3 FLIm detects GAG depletion in articular cartilage. (a) Representative fluorescence cross-sectional
intensity ratio images, LT images, and histology images of untreated and treated bovine articular
cartilage. ROIs highlight the region of GAG depletion in histology images of cABC treated sample.
The corresponding region in FLIm LT and intensity ratio images are highlighted by stars. The GAG
depletion region appears in FLIm maps with higher intensity ratio and lower LT in channel 3
as well as lower intensity ratio in channel 1. No GAG depletion is observed for control sample.
Scalebar ¼ 1 mm (n ≥ 6 per group). (b) Box plot of ROI average LT from all samples in control and
high cABC group. Significant LT differences are observed in channel 2 (450 to 485 nm) *p < 0.05
and channel 3 (530 to 565 nm) **p < 0.01. Significant differences in intensity ratio are observed in
all channels. ****p < 0.0001.
Fig. 4 (a) Representative cross-sectional FLIm LT and intensity ratio images of cartilage without treat-
ment and cartilage treated with high (2 U∕mL) and low (1 U∕mL) concentration of cABC. The depleted
region is segmented using channel 1 intensity ratio of 0.25. Scalebar ¼ 1 mm. (b) Box plot of the thick-
ness of the GAG depleted layer calculated from segmentation result **p < 0.01 (n ≥ 6 per treatment
group).
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4 Discussion
This study demonstrated that (1) fluorescence LT of articular
cartilage varies across its depth; shorter LT values were observed
for the superficial zone of cartilage when compared with the
middle and deep zones and (2) the depletion of GAG can be
detected using FLIm and the level of GAG depletion in articular
cartilage can be inferred using fluorescence-based parameters.
Both of the above points demonstrate that FLIm can detect bio-
chemical changes in cartilage tissue and has great potential for
early detection of cartilage disease.
To our knowledge, this is the first study to map the fluores-
cence features of native bovine articular cartilage across its full
thickness. The cross-sectional imaging protocol allowed us to
study changes in FLIm parameters as a function of depth.
The comparison of LT distribution obtained from cross-sectional
imaging and that from conventional en-face imaging cross-
validated the results. Given the complex zonal variation of
cell morphology, collagen fiber orientation, and biochemical
composition in articular cartilage,8 the change of fluorescence
LT across the thickness of cartilage is expected. Current results
are in agreement with earlier studies conducted on articular car-
tilage that showed shorter LT for the superficial layer relative to
middle and deep zone of the cartilage28 and a previous study that
validated en-face FLIm parameters with biochemical assays.29
These results, in conjunction with the fiber-based platform,
allow for ease of translation into imaging in humans via
augmentation of the current clinical practice of arthroscopy.
By incorporating the optical fiber into a conventional viewing
scope, this technique would enable straightforward visual evalu-
ation of the integrity of the cartilage surface and inner structures,
allow spatial or temporal monitoring during disease develop-
ment, and allow clinicians to monitor the biochemical changes
occurring within the patient.
Apart from the change of fluorescence LT as a function of
depth, macrostructures presented in both cross-section (shape
of tunnel) and en-face (round shape) exhibit shorter LT when
compared with the surrounding cartilage mass. Since cartilage
from juvenile bovine condyles was used in this study, these
microstructures could be cartilage canals that present only in
the early stage of cartilage development.30 Since cartilage canals
have different biochemical composition when compared with
the collagen-rich cartilage ECM, it is expected that these micro-
structures exhibit a different LT. This demonstrated that FLIm
could be a potential tool for studying basic biochemical proper-
ties associated with structural heterogeneities of cartilage as
well. To date, much is known about articular cartilage organi-
zation and ECM, but less is known about its developmental biol-
ogy. How articular cartilage grows and matures into a complex,
functional, and multifaced structure is still unclear. FLIm could
help advance our knowledge in these research areas by monitor-
ing the change of biochemical properties of native articular car-
tilage during its development and along its depth. The advances
will have significant impact for basic science and potential trans-
lational value to the design of superior cartilage regeneration and
rapier strategies.
The finding that the depletion of GAG significantly altered
the fluorescence features of articular cartilage tissue and
the change could be detected using our FLIm instrumentation
is of critical importance for the research of OA diagnosis, as
GAG loss is the first indicator for early OA development. This
could enable early diagnosis of OA before clinical symptoms
like pain and the appearance of cartilage loss.
We acknowledge that the freeze-thaw cycles of the cartilage
tissue before imaging lyse the cells and could alter cartilage
fluorescence properties. Thus, the experimental conditions
reported in this study might not fully mimic conditions encoun-
tered in the clinical application. In a separate study conducted
on articular cartilage using the same FLIm instrumentation, we
showed that the freezing process results in decreases in channel
1 LT (Δ ¼ 0.14; p ¼ 0.003) and significant increases in channel
2 LT (Δ ¼ 0.11; p ¼ 0.003) and channel 3 LT (Δ ¼ 0.22;
p ¼ 0.003) compared to fresh tissue. However, the changes
were small compared to those induced by the loss of GAG,
which resulted in a significant decrease of fluorescence LT
values in channel 2 (Δ ¼ 0.44 ns; p < 0.05) and channel 3
(Δ ¼ 0.75 ns; p < 0.01). The small differences in FLIm LT
values with cell lysis could be attributed to the very low
(∼10% by volume) composition of cells within cartilage tissue.
Interestingly, collagen was more densely packed in the
region of GAG depletion post-cABC treatment. This was
represented in PSR stained histology as an increase in color
saturation in the ROIs. In healthy cartilage, the collagen network
is slightly stretched due to the Donnan osmotic pressure
caused by GAG content that provides its compressive stiffness.8
Thus, the loss of GAG would lead to a slightly denser collagen
matrix.
GAG loss resulted in a significant decrease in the intensity
ratio of channels 1 and 2, which represents collagen and a
significant increase in the intensity ratio of channel 3, which
represents GAG. This nonintuitive change could be attributed to
the conformational change of collagen structure inside cartilage
tissue. It is well known that collagen cross-links strongly
fluoresce. The loss of GAG could result in the breakdown of
collagen cross-links, which was not quantified in this study.
Thus, the loss of GAG very likely resulted in the loss of absolute
intensity in all spectral channels, but the loss in channels 1 and 2
was more prominent due to the high quantum yield of collagen
and its cross-links. As intensity ratio characterizes the relative
intensity contribution of each channel instead of absolute inten-
sity, a higher absolute loss in channels 1 and 2 will result in
a decrease in channel 1 and channel 2 intensity ratios and
a higher channel 3 intensity ratio.
The decrease of fluorescence LT in channel 2 and channel 3
is a result of the intensity ratio change. Collagen is the dominant
fluorophore in cartilage and has the highest fluorescence LT
(∼5.5 ns) of the major constituents.21 The decrease of intensity
ratio in channel 1 and channel 2 indicates a lower contribution
from collagen, which would result in a significant decrease of
fluorescence LT in all channels. There is no significant change
of fluorescence LT in channel 1 as collagen fluorescence com-
pletely dominates this channel. Channel 3 had the largest LT
decrease as it sits at the tail of collagen emission spectrum
and the collagen contribution is less dominant.
A threshold-based segmentation algorithm could distinguish
high levels of GAG depletion in our cABC-treatment group
from the control group using one of the many fluorescence
parameters. However, intensity measurement is highly sensitive
to the excitation and collection geometry. Any change of
excitation and collection geometry could lead to significant
measurement error. On the other hand, fluorescence LT is robust
to the change of measurement conditions. Thus, the effective-
ness and robustness of our instrumentation to detect early OA
could be further improved by including more FLIm parameters.
Nonetheless, we demonstrated that parameters from noninvasive
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FLIm imaging can successfully detect GAG depletion in artic-
ular cartilage.
We employed raster scanning by a translation stage in this
study to automate the scanning process. In a clinical setting,
the fiber-based interface can be introduced through a standard
clinical arthroscope with the FLIm imaging data overlaid on the
arthroscope image on the surgical monitor. We have previously
demonstrated this concept using a hand scanning probe31 for
interrogation of breast cancer tumors. Real-time FLIm data
were overlaid on conventional white light images of the tissue,32
providing valuable real time feedback to the surgeons. When
combined with machine learning algorithms, real-time classifi-
cation was also possible, providing potential real-time disease
discrimination.31
We acknowledge that the cross-section imaging approach
used in this study is different from an arthroscopy imaging
situation. Future en-face imaging will be required to properly
assess the performance of FLIm instrumentation for detection of
OA and its usefulness in clinical environment. Furthermore,
we acknowledge that FLIm is only a surface imaging modality
with a penetration depth of ∼300 μm and is not able to provide
any structural information regarding the integrity of articular
cartilage. However, FLIm can be adapted to tissue interrogation
in endoscopic-like configurations,33,34 thus, it can complement
other structural imaging modalities like ultrasound and OCT.
This study serves as an important step toward early diagnosis of
OA and encourages further investigation into the feasibility of
in vivo FLIm arthroscopy.
5 Conclusion
This study demonstrates that GAG degradation in articular
cartilage can be detected by rapid, nondestructive, fiber-based
FLIm. This technique could be utilized as a potential tool for
basic research of cartilage. In addition, the size of the miniature
fiber probe, the clinically compatible high imaging speed, and
the potential for multimode imaging, such as FLIm-OCT,35
make it a promising tool for the early diagnosis of OA. This
technique has a great potential to facilitate a paradigm shift from
palliation of late disease toward OA prevention and early
intervention.
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